Cytoreductive Nephrectomy in the Era of Tyrosine Kinase and Immuno-Oncology Checkpoint Inhibitors

This article reviews the literature evaluating the benefit of CN during the evolution of systemic therapy and provides clinical recommendations for current utilization of CN in patients with mRCC.

Source: Urologic Clinics of North America - June 10, 2020 Category: Urology & Nephrology Authors: Michael J. Biles, Hiten D. Patel, Mohamad E. Allaf Source Type: research